Table 3.

Correlation Between TCEAL2 Expression and the Clinicopathological Characters of Patients with Clear Cell Renal Cell Carcinoma (TCGA)

Clinico-Pathologic Variables	No. of Cases	TCEAL2 Expression		χ2	Ρ
		Low	High
All cases	534	510	24
Gender
Male	346	332	14	7.191	0.0073**
Female	188	178	10
Age
<60	265	251	14	0.2073	0.6489
≥60	269	259	10
Tumor stage
I	268	249	19	8.518	0.0364*
II	57	56	1
III	123	120	3
IV	84	83	1
T grade
T1	274	255	19
T2	69	68	1	7.913	0.0466*
T3	180	176	4
T4	11	11	0
Years of survival
<5	510	364	17	0.0033	0.9545
≥5	24	146	7

Notes: Pearson’s χ² test; *p values < 0.05; **p values < 0.01.